Meeting ReportOncology: Clinical Therapy and Diagnosis
64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.
Francisco Garcia-Perez, Hector Valdovinos, Paulina Munguia, Irma Soldevilla-Gallardo, Sevastian Medina-Ornelas, Roberto Pedrero-Piedras, Filiberto Lemus and Joel Vargas-Ahumada
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 129;
Francisco Garcia-Perez
1Instituto Nacional de Cancerología Mexico City Mexico
2Pet/ct Imagenus - Diagnostics in Healthcare Mexico City Mexico
Hector Valdovinos
1Instituto Nacional de Cancerología Mexico City Mexico
Paulina Munguia
1Instituto Nacional de Cancerología Mexico City Mexico
Irma Soldevilla-Gallardo
1Instituto Nacional de Cancerología Mexico City Mexico
Sevastian Medina-Ornelas
1Instituto Nacional de Cancerología Mexico City Mexico
Roberto Pedrero-Piedras
1Instituto Nacional de Cancerología Mexico City Mexico
Filiberto Lemus
1Instituto Nacional de Cancerología Mexico City Mexico
Joel Vargas-Ahumada
1Instituto Nacional de Cancerología Mexico City Mexico

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.
Francisco Garcia-Perez, Hector Valdovinos, Paulina Munguia, Irma Soldevilla-Gallardo, Sevastian Medina-Ornelas, Roberto Pedrero-Piedras, Filiberto Lemus, Joel Vargas-Ahumada
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 129;
64Cu- DOTA,1-Nal(3)]-octreotide (DOTANOC) PET/CT in Neuroendocrine Tumors: Initial Experience in Single Centre in Mexico.
Francisco Garcia-Perez, Hector Valdovinos, Paulina Munguia, Irma Soldevilla-Gallardo, Sevastian Medina-Ornelas, Roberto Pedrero-Piedras, Filiberto Lemus, Joel Vargas-Ahumada
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 129;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.